【レポートの概要(一部)】
Table of Contents
Table of Contents 2
List of Tables 8
List of Figures 9
Introduction 10
Global Markets Direct Report Coverage 10
Uveitis Overview 11
Therapeutics Development 12
Pipeline Products for Uveitis – Overview 12
Pipeline Products for Uveitis – Comparative Analysis 13
Uveitis – Therapeutics under Development by Companies 14
Uveitis – Therapeutics under Investigation by Universities/Institutes 18
Uveitis – Pipeline Products Glance 19
Late Stage Products 19
Clinical Stage Products 20
Early Stage Products 21
Uveitis – Products under Development by Companies 22
Uveitis – Products under Investigation by Universities/Institutes 26
Uveitis – Companies Involved in Therapeutics Development 27
AbbVie Inc. 27
Aciont Inc. 28
Apitope International NV 29
BBB Therapeutics B.V. 30
Can-Fite BioPharma Ltd. 31
Clearside BioMedical, Inc. 32
Effimune SAS 33
Eleven Biotherapeutics Inc. 34
Endocyte, Inc. 35
Enzo Biochem, Inc. 36
EyeGate Pharmaceuticals, Inc. 37
ForSight VISION4, Inc. 38
HanAll Biopharma Co., Ltd. 39
Icon Bioscience, Inc. 40
IMMD Inc. 41
Johnson & Johnson 42
Neuroptis Biotech 43
Novartis AG 44
Ocata Therapeutics, Inc. 45
OncoNOx ApS 46
Panoptes Pharma Ges.m.b.H. 47
Pfizer Inc. 48
pSivida Corp. 49
Regeneron Pharmaceuticals, Inc. 50
Santen Pharmaceutical Co., Ltd. 51
SynDevRx, Inc. 52
TxCell SA 53
Virogenomics, Inc. 54
XOMA Corporation 55
Uveitis – Therapeutics Assessment 56
Assessment by Monotherapy Products 56
Assessment by Target 57
Assessment by Mechanism of Action 59
Assessment by Route of Administration 61
Assessment by Molecule Type 63
Drug Profiles 65
2B3-201 – Drug Profile 65
Product Description 65
Mechanism of Action 65
R&D Progress 65
adalimumab – Drug Profile 67
Product Description 67
Mechanism of Action 67
R&D Progress 67
ATXUV-1 – Drug Profile 69
Product Description 69
Mechanism of Action 69
R&D Progress 69
ATXUV-2 – Drug Profile 70
Product Description 70
Mechanism of Action 70
R&D Progress 70
B27-PD – Drug Profile 71
Product Description 71
Mechanism of Action 71
R&D Progress 71
celecoxib – Drug Profile 73
Product Description 73
Mechanism of Action 73
R&D Progress 73
CF-101 – Drug Profile 75
Product Description 75
Mechanism of Action 75
R&D Progress 75
Col-Treg – Drug Profile 77
Product Description 77
Mechanism of Action 77
R&D Progress 77
Cytectin – Drug Profile 78
Product Description 78
Mechanism of Action 78
R&D Progress 78
dexamethasone acetate – Drug Profile 79
Product Description 79
Mechanism of Action 79
R&D Progress 79
Dexamethasone Sodium Phosphate-Visulex – Drug Profile 81
Product Description 81
Mechanism of Action 81
R&D Progress 81
Drugs to Inhibit Aldose Reductase for Immunology, Ophthalmology, Infectious Disease, Metabolic and Respiratory Disorders – Drug Profile 82
Product Description 82
Mechanism of Action 82
R&D Progress 82
EBI-028 – Drug Profile 83
Product Description 83
Mechanism of Action 83
R&D Progress 83
EC-1496 – Drug Profile 84
Product Description 84
Mechanism of Action 84
R&D Progress 84
EC-1669 – Drug Profile 85
Product Description 85
Mechanism of Action 85
R&D Progress 85
fluocinolone acetonide – Drug Profile 86
Product Description 86
Mechanism of Action 86
R&D Progress 86
FR-104 – Drug Profile 88
Product Description 88
Mechanism of Action 88
R&D Progress 88
gevokizumab – Drug Profile 90
Product Description 90
Mechanism of Action 90
R&D Progress 90
HL-036 – Drug Profile 93
Product Description 93
Mechanism of Action 93
R&D Progress 93
IBI-70090 – Drug Profile 94
Product Description 94
Mechanism of Action 94
R&D Progress 94
IMD-0354 – Drug Profile 95
Product Description 95
Mechanism of Action 95
R&D Progress 95
INV-17 – Drug Profile 96
Product Description 96
Mechanism of Action 96
R&D Progress 96
LFG-316 – Drug Profile 97
Product Description 97
Mechanism of Action 97
R&D Progress 97
lodamin – Drug Profile 99
Product Description 99
Mechanism of Action 99
R&D Progress 99
NOP-3 – Drug Profile 100
Product Description 100
Mechanism of Action 100
R&D Progress 100
NS-2 – Drug Profile 101
Product Description 101
Mechanism of Action 101
R&D Progress 101
OX-1001 – Drug Profile 102
Product Description 102
Mechanism of Action 102
R&D Progress 102
PA-2612 – Drug Profile 103
Product Description 103
Mechanism of Action 103
R&D Progress 103
Peptides to Modulate TCR for Uveitis – Drug Profile 104
Product Description 104
Mechanism of Action 104
R&D Progress 104
plastoquinone decyl triphenylphosphonium bromide – Drug Profile 105
Product Description 105
Mechanism of Action 105
R&D Progress 105
PP-001 – Drug Profile 107
Product Description 107
Mechanism of Action 107
R&D Progress 107
PPL-003 – Drug Profile 108
Product Description 108
Mechanism of Action 108
R&D Progress 108
Recombinant Enzymes for Uveitis – Drug Profile 109
Product Description 109
Mechanism of Action 109
R&D Progress 109
sarilumab – Drug Profile 110
Product Description 110
Mechanism of Action 110
R&D Progress 110
sirolimus – Drug Profile 112
Product Description 112
Mechanism of Action 112
R&D Progress 112
Small Molecules to Inhibit Kinase for Uveitis and Inflammatory Bowel Disease – Drug Profile 114
Product Description 114
Mechanism of Action 114
R&D Progress 114
Stem Cell Therapy for Autoimmune Diseases – Drug Profile 115
Product Description 115
Mechanism of Action 115
R&D Progress 115
triamcinolone acetonide – Drug Profile 116
Product Description 116
Mechanism of Action 116
R&D Progress 116
V-404 – Drug Profile 117
Product Description 117
Mechanism of Action 117
R&D Progress 117
Uveitis – Recent Pipeline Updates 118
Uveitis – Dormant Projects 147
Uveitis – Discontinued Products 150
Uveitis – Product Development Milestones 151
Featured News & Press Releases 151
Jan 05, 2015: Clearside Biomedical Initiates Phase 2 Clinical Trial For the Treatment of Macular Edema Associated With Non-Infectious Uveitis 151
Dec 18, 2014: Aldeyra Therapeutics Submits FDA IND Filing for Noninfectious Anterior Uveitis 151
Dec 17, 2014: TxCell Receives EU Orphan Drug Designation For Col-Treg In The Treatment Of Non-Infectious Uveitis 152
Dec 16, 2014: Aldeyra Therapeutics Abstract Accepted at 2015 American Academy of Allergy Asthma & Immunology Annual Meeting 153
Dec 16, 2014: Portage announces further successful validation of its new proprietory cell permeable peptide platform technology 153
Oct 28, 2014: TxCell achieves positive results for Col-Treg in a model of autoimmune uveitis 154
Oct 15, 2014: Clearside Biomedical Announces Ongoing Results in Phase 1/2 Clinical Trial in Patients with Non-infectious Uveitis 155
Oct 06, 2014: Portage Announces Additional Consultants To Expedite Its PPL-003 Development Programs 155
May 22, 2014: Col-Treg granted Advanced Therapy Medicinal Product classification by the European Medicines Agency 156
May 20, 2014: AbbVie Receives Orphan Drug Designation for HUMIRA from the U.S. Food and Drug Administration for the Investigational Treatment of Certain Forms of Non-infectious Uveitis 157
Appendix 158
Methodology 158
Coverage 158
Secondary Research 158
Primary Research 158
Expert Panel Validation 158
Contact Us 158
Disclaimer 159
【レポート販売概要】
■ タイトル:ぶどう膜炎(Uveitis):治療薬開発パイプライン動向(2015年上半期版)■ 英文:Uveitis - Pipeline Review, H1 2015
■ 発行日:2015年3月11日
■ 調査会社:Global Markets Direct
■ 商品コード:GMDHC6260IDB
■ 調査対象地域:グローバル
- 手術室用装置/用品の世界市場:麻酔機械、手術台、電気手術ユニット、マルチパラメータ患者モニタ、手術用画像デバイス、手術室照明The operating room equipment & supplies market is expected to reach USD 29.15 Billion in 2020 from USD 24.31 Billion in 2015, growing at a CAGR of 3.7%. The global market is segmented on the basis of product, type, and end user. By product, the market is categorized into operating room supplies and operating room equipment. The operating room supplies are estimated to account for the largest share …
- Onglyza (Type 2 Diabetes):市場予測と分析(~2022)Onglyza (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Onglyza (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked by a late-stage pipeline filled with me-too drugs, this market will undergo substantial growth between 2012 and 2022, more …
- 熱処理空気ろ過の世界市場2017-2021About Thermal Treatment Air FiltrationThermal treatment air filtration is a method wherein heat is used to filter industrial air streams to prevent hazardous pollutants from being emitted into the atmosphere. In this technique, exhaust air is thermally heated to very high temperatures in an oxidizer chamber, which breaks down the chemical bonds of the pollutant compounds. The compounds then combin …
- ネットワーク最適化サービスの世界市場予測(~2022年):ローカルネットワーク最適化、WAN最適化、RAN最適化、データセンター最適化The network optimization services market is expected to grow from USD 4.78 Billion in 2017 to USD 9.08 Billion by 2022, at a Compound Annual Growth Rate (CAGR) of 13.7% during the forecast period. Several factors such as the increasing number of branch offices and data centers, growth in usage of Internet Protocol (IP) video and virtualization, and network optimization as a cloud service are drivi …
- Operating Room Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018Operating Room Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Summary GlobalData’s new report, “Operating Room Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018” provides key market data on the Operating Room Equipment market in the BRICS countries. The report provides value ($m), volume (units) and average price ($) data …
- 量子ドットの世界市場:製品(ディスプレイ、医療機器、バッテリー、太陽電池、センサ)、量子ドット材料、用途、地域別分析The quantum dot market report analyzes the ecosystem of the quantum dot industry, and the key market based on the product includes medical devices, display, and others. The others segment consists of solar cell, chip, sensor, lighting, battery and energy storage, QD laser, and transistor. The application segment covers the market share of different applications for the quantum dot market. The repo …
- スタジアム照明の世界市場:光源別(LED、HPS、HID、インダクションライト、その他)、提供別(ランプ・照明器具、サービス、制御システム)、ソリューションのセットアップ別(屋外、屋内)、設置別(レトロフィット、新規設置)、地域別予測Global Stadium Lighting Market to reach USD 717.2 million by 2025. Global Stadium Lighting Market valued approximately USD 369.1 million in 2016 is forecasted to grow with a healthy growth rate of more than 7.66% over the forecast period 2018-2025. The major factors speculated to augment the markets are upcoming national & international sports events, lessening costs of LEDs & life-cycle operating …
- Petroleo Brasileiro S.A.:石油・ガスバリューチェーン分析レポート2013Petroleo Brasileiro S.A. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Petroleo Brasileiro S.A." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Petroleo Brasileiro S.A.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The …
- 家庭用清掃器具・清掃用品の世界市場2017-2021ABSTRACTAbout Household Cleaning Tools and Supplies Household cleaning tools are used to clean the floors, walls, corners, and edges of houses. Sourcing pads, scrubbers, and sponges; mops and brooms; cleaning brushes; wipes; gloves; and soap dispensers, buckets, and dustpans are different types of cleaning tools that are widely used in households. Household cleaning tools primarily include sourcin …
- 世界の軍事シミュレーション及び仮想訓練市場:地域別分析Summary This report offers detailed analysis of the global Military Simulation and Virtual Training market over the next ten years, and provides extensive market size forecasts by country and sub sector. It covers the key technological and market trends in the Military Simulation and Virtual Training market. Key Findings "The Global Military Simulation and Virtual Training Market 2015-2025 - Count …
- ジルコニウム及びハフニウムの世界市場動向2014/2015The report presents a thorough study of zirconium and hafnium, covering both global and regional markets. It aims to give a proper picture of the market, its trends, perspectives and opportunities. Comprehensive data showing zirconium and hafnium worldwide production, consumption, trade statistics and prices are provided. Each country’s market overview covers the following: zirconium and hafnium p …
- マイクログリッド向けエネルギー貯蔵の世界市場About microgrids Microgrids are remote grids that can operate independently from conventional grid networks. They have control capabilities and are geared to connect to a main grid at a point of coupling that can maintain the voltage at the same levels as the main grid. These grids are also capable of negating instabilities by enabling the deployment of renewable energy sources such as solar PV an …
- 遠隔患者監視装置の世界市場分析:製品別(生存兆候モニター、専門モニター)、エンドユーザー別(病院の患者、その他(外来患者、在宅医療))、用途別、セグメント予測、2014-2025Global remote patient monitoring devices market is expected to reach USD 1.9 billion by 2025, according to a new report by Grand View Research Inc. Remote patient monitoring devices, due to their capability to monitor various chronic conditions such as diabetes, cardiovascular conditions and cancer are expected to witness substantial growth over the forecast period. Increasing incidences of cardio …
- グリースの世界市場:金属石けん系増ちょう剤、非石けん系増ちょう剤、無機増ちょう剤The global grease market is projected to reach USD 2.28 Billion by 2021, registering a CAGR of 2.0% between 2016 and 2021. The growth of the market is primarily driven by the automotive industry. Automobile uses grease in various parts, such as wheel bearings, ball and steering joints, universal joints, chassis, suspensions, gears, switches, and connectors. The automotive industry dominated the gr …
- 止血剤・組織密閉剤の世界市場:製品別(局所止血剤、接着剤・組織シーラント)、地域別、セグメント予測The global hemostasis and tissue sealing agents market size is expected to reach USD 10.34 billion by 2026, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 8.7% during the forecast period. The agents have gained popularity over time due to their ability to prevent blood loss. Rapid growth of minimal invasive technology and demand for faster recovery by …